Clinical trials sponsored by Fujian Shengdi Pharmaceutical Co., Ltd.

Phase breakdown

Conditions studied

Recruiting trials led by Fujian Shengdi Pharmaceutical Co., Ltd.

• A Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Tablets in Overweight or Obese Subjects
  NCT07670884 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity Who Are on Positive Airway Pressure Ventilation (PAP) Therapy
  NCT06994650 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Multicenter, Randomized, Open, Parallel-designed Study to Evaluate the Efficacy and Safety of HRS-5635 Injection Alone or in Combination With Other Agents in Patients Treated for Chronic Hepatitis B
  NCT06425341 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-5817 Injection
  NCT06934408 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• A Research Study to Investigate the Efficacy and Safety of HRS9531 Tablets in Participants With Type 2 Diabetes Mellitus
  NCT07599410 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 2 locations
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS9531 Injection in Adolescents With Obesity
  NCT07559136 · Phase: Phase 1 · Ages: 12 Years to 18 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety of HRS9531 in Participants With Type 2 Diabetes Treated With Basal Insulin
  NCT07060456 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Phase II Clinical Study of HRS-9057 Injection in Patients With Heart Failure-induced Fluid Retention
  NCT07318103 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Phase III Study of HRS-5635 in Nucleos(t)Ide Analogue-suppressed HBeAg-negative Patients With Chronic Hepatitis B
  NCT07606950 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Relative Bioavailability of First vs Second-Generation Formulations of HRS9531 Tablets in Obese or Overweight Subjects
  NCT07150962 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is Fujian Shengdi Pharmaceutical Co., Ltd. recruiting for?

Fujian Shengdi Pharmaceutical Co., Ltd. is the lead sponsor of 10 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.